Boston Scientific Corp (BSX)
Current ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 6,920,000 | 6,514,000 | 5,760,000 | 6,317,000 | 6,694,000 |
| Total current liabilities | US$ in thousands | 6,399,000 | 4,933,000 | 3,803,000 | 4,274,000 | 3,681,000 |
| Current ratio | 1.08 | 1.32 | 1.51 | 1.48 | 1.82 |
December 31, 2024 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $6,920,000K ÷ $6,399,000K
= 1.08
The current ratio of Boston Scientific Corp has shown a gradual decline over the years, dropping from 1.82 in December 2020 to 1.08 in December 2024. This decreasing trend could potentially indicate a weakening liquidity position, as the company may be less able to cover its short-term obligations with its current assets. It is essential for investors and stakeholders to monitor this ratio closely, as a current ratio below 1 may signal financial distress. Further analysis of Boston Scientific Corp's cash flow and working capital management strategies would be advisable to better understand the factors contributing to this declining trend.
Peer comparison
Dec 31, 2024